View an illustration of immune cells responding to an invading virus.
Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.
Research to Advance Vaccine Safety (R01 and R21)
HIV Vaccines: Where We Are and Where We’re Headed
Vaccine Research Center (VRC) Boosts Research on Vaccines for HIV and Other Diseases
Experimental Vaccine Shows Promise in Preventing Cytomegalovirus Infection—March 18, 2009
NIAID Media Availability: New Technology Opens Gateway to Studying HIV-Specific Neutralizing Antibodies—March 15, 2009
Study Reveals Link between Apobec3 Gene and Neutralizing Antibody Response to Retrovirus—Sept. 4, 2008
NIAID to Fund Broad Range of Basic HIV Vaccine Discovery Research—Aug. 29, 2008
NIAID Media Availability: NIAID Describes Challenges, Prospects for an HIV Vaccine—Aug. 27, 2008
NIAID Media Availability: NIAID Announces Revised Priorities for HIV Vaccine Research—July 24, 2008
NIAID Media Availability: Scientists Discover How Common Vaccine Booster Works—May 21, 2008
All vaccine news and events
Pneumococcal infections account for more than 1.6 million deaths each year, mostly in the world’s poorest countries. Read how scientists working in rural Africa evaluated a promising vaccine against pneumoccocal disease.
Volunteer for NIAID-funded clinical studies related to vaccines on ClinicalTrials.gov.
View a list of links for more information about vaccines.